Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4547964
Max Phase: Preclinical
Molecular Formula: C49H85N3O15
Molecular Weight: 956.22
Molecule Type: Unknown
Associated Items:
ID: ALA4547964
Max Phase: Preclinical
Molecular Formula: C49H85N3O15
Molecular Weight: 956.22
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCNC(=O)C(C[C@H]1C[C@@H](C)C(=O)/C=C/C(C)=C/[C@H](CO[C@H]2O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]2OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]1O)N(C)C(=O)CCC
Standard InChI: InChI=1S/C49H85N3O15/c1-14-17-21-50-47(60)34(52(11)38(55)18-15-2)24-32-23-28(5)35(53)20-19-27(4)22-33(26-63-49-46(62-13)45(61-12)42(58)31(8)65-49)37(16-3)66-39(56)25-36(54)29(6)44(32)67-48-43(59)40(51(9)10)41(57)30(7)64-48/h19-20,22,28-34,36-37,40-46,48-49,54,57-59H,14-18,21,23-26H2,1-13H3,(H,50,60)/b20-19+,27-22+/t28-,29+,30-,31+,32-,33-,34?,36-,37-,40+,41-,42+,43-,44-,45+,46+,48+,49+/m1/s1
Standard InChI Key: LHGVSDFFVOYJTO-GCVCGNSNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 956.22 | Molecular Weight (Monoisotopic): 955.5981 | AlogP: 2.91 | #Rotatable Bonds: 18 |
Polar Surface Area: 232.32 | Molecular Species: NEUTRAL | HBA: 16 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.54 | CX Basic pKa: 7.94 | CX LogP: 3.41 | CX LogD: 2.76 |
Aromatic Rings: 0 | Heavy Atoms: 67 | QED Weighted: 0.10 | Np Likeness Score: 1.22 |
1. Budragchaa T, Westermann B, Wessjohann LA.. (2019) Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria., 27 (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046] |
Source(1):